GUARDANT HEALTH INC's ticker is GH and the CUSIP is 40131M109. A total of 221 filers reported holding GUARDANT HEALTH INC in Q2 2019. The put-call ratio across all filers is 1.22 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $230,000 | -33.7% | 3,468 | 0.0% | 0.00% | -33.3% |
| Q4 2021 | $347,000 | -20.0% | 3,468 | 0.0% | 0.00% | -25.0% |
| Q3 2021 | $434,000 | +2.4% | 3,468 | +1.5% | 0.00% | 0.0% |
| Q2 2021 | $424,000 | -20.5% | 3,418 | -2.1% | 0.00% | -20.0% |
| Q1 2021 | $533,000 | -18.4% | 3,490 | -31.1% | 0.01% | -28.6% |
| Q4 2020 | $653,000 | +15.4% | 5,065 | 0.0% | 0.01% | 0.0% |
| Q3 2020 | $566,000 | +43.3% | 5,065 | +4.1% | 0.01% | +40.0% |
| Q2 2020 | $395,000 | -99.7% | 4,865 | +134.3% | 0.01% | +150.0% |
| Q1 2020 | $144,490,000 | -68.9% | 2,076 | -65.1% | 0.00% | -66.7% |
| Q4 2019 | $464,620,000 | +50.2% | 5,946 | +22.7% | 0.01% | +50.0% |
| Q3 2019 | $309,256,000 | -26.1% | 4,845 | 0.0% | 0.00% | -33.3% |
| Q2 2019 | $418,269,000 | +22.4% | 4,845 | +8.8% | 0.01% | +20.0% |
| Q1 2019 | $341,699,000 | +60.5% | 4,455 | -21.4% | 0.01% | +66.7% |
| Q4 2018 | $212,947,000 | – | 5,665 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Blue Water Life Science Advisors, LP | 390,945 | $39,102,000 | 11.96% |
| Iron Triangle Partners LP | 440,255 | $44,034,000 | 6.14% |
| Adalta Capital Management LLC | 110,260 | $11,028,000 | 5.08% |
| Ally Bridge Group (NY) LLC | 105,000 | $10,502,000 | 3.67% |
| Eagle Health Investments LP | 119,360 | $11,938,000 | 2.91% |
| Casdin Capital, LLC | 790,000 | $79,016,000 | 2.23% |
| AtonRa Partners | 54,163 | $5,417,000 | 1.88% |
| Steadfast Capital Management (UK) Ltd. | 14,686 | $1,469,000 | 1.77% |
| STEADFAST CAPITAL MANAGEMENT LP | 1,009,031 | $100,923,000 | 1.66% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 74,500 | $7,451,000 | 1.66% |